Clinical Trial Detail

NCT ID NCT02843165
Title Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Diego
Indications

Advanced Solid Tumor

Therapies

unspecified PD-L1 antibody

unspecified CTLA4 antibody

unspecified PD-1 antibody

Age Groups: adult senior

No variant requirements are available.